Difopein

Difopein (CAS No.: 396834-58-5) is a synthetic peptide-based inhibitor of 14-3-3 proteins, a highly conserved family of regulatory molecules that participate in diverse cellular processes including signal transduction, vesicular trafficking, cell cycle progression, DNA replication and repair, and apoptosis. By disrupting 14-3-3 protein–protein interactions, Difopein serves as a valuable research tool for interrogating the functional roles of this signaling hub in oncogenic pathways and cellular survival mechanisms. In glioma cell models such as U251 and U87, Difopein has been shown to induce apoptosis in a time-dependent manner, characterized by nuclear fragmentation, DNA laddering, and formation of membrane-bound apoptotic bodies, alongside modulation of key apoptotic regulators including downregulation of Bcl-2, upregulation of Bax, and activation of caspase-9 and caspase-3. These findings highlight its utility in studying mitochondrial apoptotic pathways and stress response signaling. In vivo studies using tumor xenograft models further demonstrate its capacity to suppress tumor cell proliferation and promote apoptosis, supporting its application in mechanistic cancer biology research. Difopein is commonly employed in cell-based assays and animal studies to investigate 14-3-3-mediated signaling networks, with experimental concentrations or dosing regimens varying depending on specific study designs and endpoints.